How the DNA’s environment shapes smoking-related cancer risk
The study from The Hebrew University of Jerusalem, led by Prof. Sheera Adar and her…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Ovarian cancer discovery could turn failed treatment into lifesaver
University of Virginia Cancer Centre researchers (USA) have explained the failure of immune checkpoint therapy…
SETDB1 amplification identified as a potential target for new osteosarcoma treatment
In a new review published in Oncotarget, authors Elodie Verdier, Nathalie Gaspar, Maria Eugenia Marques…
Utilising a nanomedicine to achieve tumour catalysis-enhanced differentiation therapy
Tumour metastasis, recurrence, and therapeutic resistance are the main reasons for the failure of clinical…
S3E1 The Oncology Journal Club: ASCO GI Highlights 2025
Welcome to Episode 1 of the Third Series of The Oncology Journal Club! Our Hosts Professor Craig Underhill and Professor Christopher Jackson are joined by Professor Chris Karapetis to unpack the ASCO GI 2025 meeting.
Tweaking cancer cell response to ultrasound treatment
Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular…
Self-protecting nanoparticles for effective treatment of colorectal cancer
Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a…
Unraveling the role of the Wnt pathway in hepatocellular carcinoma: From molecular mechanisms to therapeutic implications
Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality…
Study reveals genes that may help predict prostate cancer outcomes
A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of…
Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer
Patients with localised muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors…